Literature DB >> 8834582

Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy.

P H Sugarbaker1.   

Abstract

The rationale and the treatment strategies for peritoneal carcinomatosis have gained prominence over the last decade. Their definite contribution to the management of gastrointestinal cancer has been established. The significant contributions are summarized in Table 7.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8834582     DOI： 10.1007/978-1-4613-1245-1_13

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


  19 in total

1.  Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.

Authors:  Meng Ye; Hong-Ming Pan; Hai-Yun Wang; Fang Lou; Wei Jin; Yu Zheng; Jin-Ming Wu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

2.  Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis.

Authors:  Christina Karamveri; Nicolaos Pallas; Dimitrios Kyziridis; Christos Hristakis; Vasileios Kyriakopoulos; Apostolos Kalakonas; Dimitrios Vaikos; Antonios-Apostolos K Tentes
Journal:  Indian J Surg Oncol       Date:  2018-05-19

3.  Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Antonio Martino; Giuseppe Confuorto
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity.

Authors:  Franco Roviello; Daniele Marrelli; Alessandro Neri; Daniela Cerretani; Giovanni de Manzoni; Corrado Pedrazzani; Tommaso Cioppa; Giacomo Nastri; Giorgio Giorgi; Enrico Pinto
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

5.  Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Sebastian Zuber; Jens Otto; Lothar Tietze; Volker Schumpelick
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

6.  Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.

Authors:  Tommaso Cioppa; Marco Vaira; Camilla Bing; Silvia D'Amico; Alessandro Bruscino; Michele De Simone
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 7.  Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

Authors:  J Spiliotis; E Halkia; E de Bree
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

8.  Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.

Authors:  W Yu; I Whang; I Suh; A Averbach; D Chang; P H Sugarbaker
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

Review 9.  The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.

Authors:  Mackenzie C Morris; Jordan M Cloyd; John Hays; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2020-08-17       Impact factor: 3.452

10.  Phospholipids reduce the intraperitoneal adhesion of colonic tumor cells in rats and adhesion on extracellular matrix in vitro.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Jens Otto; Britta Schmitz; Stefan Mueller; Claudia Weiss; Lothar Tietze; Volker Schumpelick
Journal:  Int J Colorectal Dis       Date:  2004-08-12       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.